BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1862165)

  • 1. Heterogeneity of schizophrenia: relationship to latency of neuroleptic response.
    McDermott BE; Sautter FJ; Garver DL
    Psychiatry Res; 1991 Apr; 37(1):97-103. PubMed ID: 1862165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
    Crespo-Facorro B; Pelayo-Terán JM; Pérez-Iglesias R; Ramírez-Bonilla M; Martínez-García O; Pardo-García G; Vázquez-Barquero JL
    J Psychiatr Res; 2007 Oct; 41(8):659-66. PubMed ID: 16797591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase.
    Weiser M
    Am J Psychiatry; 2011 Aug; 168(8):761-3. PubMed ID: 21813489
    [No Abstract]   [Full Text] [Related]  

  • 4. Premorbid personality and positive and negative symptoms in schizophrenia.
    Peralta V; Cuesta MJ; de Leon J
    Acta Psychiatr Scand; 1991 Oct; 84(4):336-9. PubMed ID: 1746284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizotypal disorder.
    Battaglia M; Bellodi L
    Hosp Community Psychiatry; 1992 Jan; 43(1):82-3. PubMed ID: 1544660
    [No Abstract]   [Full Text] [Related]  

  • 6. An independent analysis of the Danish Adoption Study of Schizophrenia. VI. The relationship between psychiatric disorders as defined by DSM-III in the relatives and adoptees.
    Kendler KS; Gruenberg AM
    Arch Gen Psychiatry; 1984 Jun; 41(6):555-64. PubMed ID: 6732417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.
    Serban G; Siegel S
    Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.
    Gomez JC; Crawford AM
    J Clin Psychiatry; 2001; 62 Suppl 2():6-11. PubMed ID: 11232753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
    Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
    Acta Psychiatr Belg; 1983; 83(1):57-68. PubMed ID: 6613612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying vulnerability markers in prodromal patients: a step in the right direction for schizophrenia prevention.
    Knowles L; Sharma T
    CNS Spectr; 2004 Aug; 9(8):595-602. PubMed ID: 15273652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schizophrenics in the doctor's office. Diagnostic and therapeutic aspects].
    Bottlender R; Möller HJ
    MMW Fortschr Med; 2004 May; 146 Spec No 2():19-23. PubMed ID: 15376697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Descriptive approach to latent forms of schizophrenia].
    Rivet B; Bougerol T; Cura B; Llorca PM; Lançon C; Scotto JC
    Encephale; 1994; 20(1):17-25. PubMed ID: 8174507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective observations of emerging psychosis.
    Rosen JL; Woods SW; Miller TJ; McGlashan TH
    J Nerv Ment Dis; 2002 Mar; 190(3):133-41. PubMed ID: 11923647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement.
    Bartkó G; Herczeg I; Békésy M
    J Clin Psychiatry; 1987 Sep; 48(9):363-5. PubMed ID: 3624207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia.
    Takahashi T; Suzuki M; Zhou SY; Tanino R; Nakamura K; Kawasaki Y; Seto H; Kurachi M
    Schizophr Res; 2010 Jun; 119(1-3):65-74. PubMed ID: 20051316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom assessment in schizophrenic prodromal states.
    Miller TJ; McGlashan TH; Woods SW; Stein K; Driesen N; Corcoran CM; Hoffman R; Davidson L
    Psychiatr Q; 1999; 70(4):273-87. PubMed ID: 10587984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenia simplex, schizotypal disorder and compulsions. Differential diagnostic considerations].
    Röhricht F; Mackert A
    Psychiatr Prax; 1998 Jan; 25(1):44-6. PubMed ID: 9530769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodromal symptoms of schizophrenia.
    Hopkins RS
    Br J Psychiatry; 1994 Aug; 165(2):268-9. PubMed ID: 7953045
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of schizophrenia in character disordered patients.
    Fenton WS; McGlashan TH
    Am J Psychiatry; 1989 Oct; 146(10):1280-4. PubMed ID: 2782471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of schizophrenia: a review of onset and duration issues.
    Keith SJ; Matthews SM
    Schizophr Bull; 1991; 17(1):51-67. PubMed ID: 2047789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.